This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.
ConclusionsSGLT2 inhibitors in patients with diabetes were independently associated with reduction in atherothrombotic major adverse cardiovascular events, allcause mortality, cardiovascular mortality, myocardial infarction, stroke, and incident dialysis, compared with DPP4 inhibitors.
We used conditional logistical regression models to estimate odds ratios and 95% CIs.RESULTS:There were 237 667 index admissions with AIS and diabetes during the study period. These results, if confirmed in other studies, emphasize the importance of avoiding hypoglycemic events in patients with diabetes.
UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg. AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019. When these results are applied across the U.S., adult population.
Aims The aim of this study was to investigate a real-world heart failure (HF) cohort regarding (1) prevalence of known diabetes mellitus (DM), undiagnosed DM and pre-diabetes, (2) if hf treatment differs depending on glycaemic status and (3) if treatment of DM differs depending on HF phenotype.
Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Hypertension and diabetes were independent risk factors for pre-eclampsia. It is not known whether heart failure increases the risk of pre-eclampsia.
Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.
Comorbidities like diabetes, hyperlipidemia, obesity, and hypothyroidism were less common in CUD patients, but substance abuse and mental health disorders were more prevalent. From 2016 to 2019, CUD among stroke survivors rose from 0.24% to 0.37%. vs. 45.1%), with a larger representation of black individuals (30.8% vs. 28.4%).
Background:The current AHA stroke prevention guidelines give Class 1 recommendations that patients with AIS and diabetes should receive glucose-lowering agents with cardiovascular benefit to reduce risk of MACE. Patients were identified to have diabetes as derived by the Charlson Comorbidity Index ICD 10 codes E10 through E14.
Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.
BackgroundPostpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk factor for ischemic heart disease. Journal of the American Heart Association, Ahead of Print.
Diabetes (16.3% We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% in 2020 to 61.0% to 26.8%) and obesity (43.1%
However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovascular disease (CVD), especially in patients with type 2 diabetes (T2D).
Diabetes Care, Mardil Medical, and Catheter Robotics. Englund brings over 25 years of experience in the medical device industry, most recently serving as Senior Vice President, Scientific Affairs at Monteris Medical, where she established a strong clinical portfolio that was pivotal in achieving reimbursement and clinical guideline status.
link] A 62 year old man with a history of hypertension, type 2 diabetes mellitus, and carotid artery stenosis called 911 at 9:30 in the morning with complaint of chest pain. From My Comment in the November 14, 2019 post in Dr. Smith's ECG Blog: A subject well worth periodic review — is the concept of Terminal QRS Distortion ( T-QRS-D ).
1.09]) in 2021 compared with 2019. 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 1.08]) increased and diabetes focused visits and insulin use remained stable. However, routine visits (RR 0.96 [0.94-0.98])
x) from 2016‐2019. The rate of 30‐day readmission was overall stable (7.34% in 2016 and 7.70% in 2019; p=0.42), but the 90‐day readmission rate slightly increased from 11.69% in 2016 to 12.47% in 2019 (p=0.04). ConclusionThe annual rate of 90‐day readmission, but not 30‐day readmission, increased from 2016 to 2019.
We aimed to examine the incidence of and risk factors for cardiotoxicity in a racially and ethnically diverse cohort with cancer treated with anthracyclines.MethodsWe included consecutive adult patients who underwent anthracyclinebased chemotherapy from 2016 to 2019 for any type of cancer. ResultsA total of 743 individuals were included (28.0%
The multivariate model (area under curve = 0.93) had three significant predictors: diabetes mellitus (aOR 36.5, For inclusion, patients must have been successfully recanalized by mechanical thrombectomy with or without intravenous thrombolytic and ultimate modified thrombolysis in cerebral infarction (mTICI) score 2B/2C/3.
0.86, p<0.001) showed that patients had a higher likelihood of excellent recanalization with lower admission NIHSS (aOR 0.93, p = 0.036), no history of diabetes mellitus (DM) (aOR 0.42, p = 0.050), no prior stroke (aOR 0.27, p = 0.007), cerebral blood volume (CBV) index >= 0.7 (aOR excellent) revascularization.
x) from 2016‐2019 using the Nationwide Readmission Database (NRD). Data was weighted to allow for representative nationwide estimates.ResultsA total of 260,854 patients were admitted with a primary diagnosis of ICH between 2016‐2019. The mean age of the cohort was 68.49 years, with 52.6% being male.
This is a focused update to the 2019 NLA Scientific Statement on the Use of Lipoprotein(a) in Clinical Practice. Untangling the Statins and Diabetes Link : Dr. Savitha Subtamaniam explored the incidence of diabetes associated with statin use, noting that the mechanism is unclear. Targeting apoB to Lower ASCVD Risk : Dr.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
million (2019) and projected to reach 4.90 Stroke, Volume 55, Issue Suppl_1 , Page A52-A52, February 1, 2024. Background/Purpose:Stroke imposes a substantial healthcare burden, with ischemic stroke (IS) mortality rising from 2.04 million (1990) to 3.29 million by 2030 according to the Global Burden of Disease Study.
We aimed to investigate prevalence of prediabetes among people according to sleep apnea status.Methods:This cross-sectional study included 10131 Korean adults without diabetes with information of STOP-Bang score were identified from the dataset of the Korea National Health and Nutrition Examination Survey 2019-2021.
GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.
We evaluated the association between pretreatment clinical, imaging, and interventional parameters in patients who achieved mTICI 2c/3 versus 2b using multivariate logistic regressions.RESULTSFrom May 11, 2019 to October 9, 2022, 149 consecutive patients met our inclusion criteria (median 70 years old [interquartile range 65–78.5], 57.7%
This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. Survey procedures were applied using SAS 9.4.Results:We
between 2016-2019, but then dropped to 1.02% in 2020. The average annual screening rate of syphilis (1.19%) was significantly lower than that of HbA1c (58%; p=0.002) and LDL (69.0%; p<0.001). Annual screening rates increased from 0.44% to 2.5%
Clinical and neuroimaging predictors of an unfavorable discharge outcome (modified Rankin score 4) were assessed in univariate and multivariable models.Results:Between 2003 and 2019, 1,791 patients were admitted with non-traumatic ICH.
We utilized a multi-state database to examine myocardial infarction (MI) risk post stroke or CAD to estimate cardiovascular complication risk.Method:We analyzed State Inpatient Database from New York (2011-2017) and Florida (2011-2019). 5.21, P < 0.001; HR 1.67, 95% CI 1.02-2.73, 2.06, P = 0.60) (Figure). 1.58, P = 0.42).Conclusion:This
Methods:We extracted data from our stroke registry for consecutive patients with acLVO who underwent EVT and subsequent neurocritical care (12/2019-12/2022). vs. 45.4%; p=0.01), had higher baseline NIHSS scores (17 [7] vs. 15 [9.5]; p=0.001), lower baseline ASPECTS (7 [3] vs. 8 [2]; p<0.001) and higher diabetes prevalence (45.9%
Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heart disease. 2019 Sep 10;74(10):1304-1314. Poor Sleep Is A Major Risk Factor For Insulin Resistance. Insulin resistance is a significant driver of cardiovascular risk. Obesity (Silver Spring). 2023 May;31(5):1204-1215.
Shortly thereafter in 2016 and 2019, the American Cardiology Association and American Diabetes Association , respectively, recommended the Mediterranean diet as a healthy dietary pattern to help prevent cardiovascular diseases and type two diabetes.
Methods:We retrospectively collected baseline demographic, clinical, and radiographic data on 27 patients who presented as a stroke alert within 24 hours of symptoms and had extensive (from bifurcation to distal ICA) occlusion by computerized tomography angiography from 2019-2023 at our institution.
His medical history includes hypertension, a decade-long battle with diabetes, ischemic heart disease, a coronary bypass graft surgery ten years ago, a diagnosis of congestive heart failure for the last five years, and a prior ICD implantation five years ago.
Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrial fibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting. Am J Med 2019, 132(5):622-630.
What do you think would happen to someone's blood pressure, LDL cholesterol, or blood glucose if you were to evaluate what happens after you stop their blood pressure, cholesterol-lowering, or diabetes medication? 2019 Aug 18;9(8):e029966. Diabetes Obes Metab. The exact same thing. But we know one thing for certain.
Past medical history included diabetes and hypertension. Finally — Note that there is also T-QRS-D ( T erminal QRS D istortion ) in lead V3 ( See My Comment in the November 14, 2019 post for review and illustration of T-QRS-D criteria ). Vitals were normal. There’s normal sinus rhythm, RBBB, normal axis and normal voltages.
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. Because a diagnosis of diabetes is very likely to shorten your life. Pre-Diabetes.
A 50-something male with unspecified history of cardiomyopathy presented in diabetic ketoacidosis (without significant hyperkalemia) with a wide complex tachycardia and hypotension. Bedside echo showed "mildly reduced" LV EF. Here is the ED ECG: What do you think? Analysis: there is a wide complex tachycardia. It is regular.
A 40-something woman with diabetes and peripheral vascular disease who frequently needs the ED for chronic pain called 911 for sudden severe chest pain. The patient was very agitated and could not hold still. I greeted medics at the door to view the prehospital ECG.
Written by Pendell Meyers, sent by Anonymous A man in his 50s with history of type 2 diabetes, HTN, and HLD presented with one day of off and on chest / upper abdominal pain. It had awoken him from sleep earlier, and he described it as "gas pain," located in the upper epigastrium and radiating upwards. Vitals were within normal limits.
A 50 something-year-old man with a history of newly diagnosed hypertension and diabetes, for which he did not take any medication, presented a non-PCI-capable center with a vague, but central chest pain. 2019 Apr;21(5):253-258. Written by Emre Aslanger. Emre is a new Editor of the Blog. He is an interventionalist in Turkey. 2019.09465.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content